PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)

$144.76 -6.28 (-4.1578%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 81

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) News Sources

Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards

21-05-2026

yahoo.com

Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043

27-05-2026

yahoo.com

Palvella Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

02-06-2026

yahoo.com

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

03-06-2026

yahoo.com

Palvella Therapeutics (PVLA) Stock Valuation Check After Strong Recent Momentum

16-06-2026

yahoo.com

FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations

22-06-2026

yahoo.com

Palvella Shares Advance After FDA Grants Rolling Review for Rare Disease Therapy

22-06-2026

advfn.com

What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally

27-06-2026

fool.com

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

29-06-2026

yahoo.com

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

30-06-2026

yahoo.com

PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) Sentiment Trend

0 25 50 75 100 88 67 87 68 81 79 89 92 74 83 21-05-2026 27-05-2026 02-06-2026 03-06-2026 16-06-2026 22-06-2026 27-06-2026 29-06-2026 30-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) FAQs

toggle

What is the current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?

The current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is $144.76.


toggle

PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) absolute price change since previous trading day?

The absolute price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is $-6.28.


toggle

PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) percentage price change since previous trading day?

The percentage price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is -4.1578%.


toggle

What is the most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?

The most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is 81 out of 100.


toggle

What is the most recent average sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?

The most recent sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is .


SEC-8K** Filing Available For PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.